Nobuhiko Takahashi, Miho Nagamine, Satoshi Tanno, Wataru Motomura, Yutaka Kohgo, Toshikatsu Okumura. A diacylglycerol kinase inhibitor, R59022, stimulates glucose transport through a MKK3/6-p38 signaling pathway in skeletal muscle cells. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2007. 360. 1. 244-250
W Motomura, M Inoue, T Ohtake, N Takahashi, M Nagamine, S Tanno, Y Kohgo, T Okumura. Up-regulation of ADRP in fatty liver in human and liver steatosis in mice fed with high fat diet. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2006. 340. 4. 1111-1118
W Motomura, S Tanno, N Takahashi, M Nagamine, M Fukuda, Y Kohgo, T Okumura. Involvement of MEK-ERK signaling pathway in the inhibition of cell growth by troglitazone in human pancreatic cancer cells. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2005. 332. 1. 89-94
S Takeuchi, T Okumura, W Motomura, M Nagamine, N Takahashi, Y Kohgo. Troglitazone induces G1 arrest by p27(Kip1) induction that is mediated by inhibition of proteasome in human gastric cancer cells. JAPANESE JOURNAL OF CANCER RESEARCH. 2002. 93. 7. 774-782
MISC (4件):
W Motomura, M Nagamine, S Tanno, M Sawamukai, N Takahashi, Y Kohgo, T Okumura. Inhibition of cell invasion and morphological change by troglitazone in human pancreatic cancer cells. JOURNAL OF GASTROENTEROLOGY. 2004. 39. 5. 461-468
W Motomura, N Takahashi, M Nagamine, M Sawamukai, S Tanno, Y Kohgo, T Okumura. Growth arrest by troglitazone is mediated by p27(Kip1) accumulation, which results from dual inhibition of proteasome activity and Skp2 expression in human hepatocellular carcinoma cells. INTERNATIONAL JOURNAL OF CANCER. 2004. 108. 1. 41-46